Response to ouabain in acutely and chronically failed canine heart-lung preparations

The actions of ouabain were studied in canine heart-lung preparations (HLP) under four different sets of procedures and the therapeutic, irregularity and lethal doses of ouabain determined. Two different methods than those usually used for producing failure in HLP are presented. Acute heart failure...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmacology 1970-01, Vol.11 (3), p.269-277
Hauptverfasser: Spilker, Bert, Hayden, Michael
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 277
container_issue 3
container_start_page 269
container_title European journal of pharmacology
container_volume 11
creator Spilker, Bert
Hayden, Michael
description The actions of ouabain were studied in canine heart-lung preparations (HLP) under four different sets of procedures and the therapeutic, irregularity and lethal doses of ouabain determined. Two different methods than those usually used for producing failure in HLP are presented. Acute heart failure was produced by either elevating Starling resistance or administering an excessive amount of the beta-adrenoceptive blocking agent, propranolol. Surgically induced heart-failure was produced by reducing the size of dogs aortae to 20–25% of its original diameter. Ouabain elicited a marked inotropic response in HLP in all three of these procedures, although the response was more rapid in onset in preparations failed acutely than in those which were normal or chronically failed. An increase of dp/dt was found to be a more sensitive criterion of ouabain's beneficial effect, than were criteria formerly used, i.e. an increase in cardiac output or a decrease in right atrial pressure. Our results are in agreement with the view that it is difficult to elicit a beneficial effect to ouabain in normal HLP, but that ouabain's effects may be easily demonstrated in failed preparations. This study demonstrated that the myocardium from chronically failed animals is more sensitive to ouabain in vitro than is the myocardium of normal animals.
doi_str_mv 10.1016/0014-2999(70)90001-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_84759330</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0014299970900014</els_id><sourcerecordid>84759330</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-e03fd30aa61ae5d5040e3c64fe9f337df882db29480adcf3e977545566df8c203</originalsourceid><addsrcrecordid>eNp9kFtLxDAQhYMoul7-gUKfRB-qaZM0zYsgizcQBNHnMJtM3Ug3rUkr7L83dRcfhYFhcs6cIR8hpwW9KmhRXVNa8LxUSl1IeqloGnO-Q2ZFLVVOZVHuktmf5YAcxviZPEKVYp_sCy4lo3xG3l4x9p2PmA1d1o2wAOezVGDGAdt1Bt5mZhk67wy0aW7AtZiewDuP2RIhDHk7-o-sD9hDgMGlsGOy10Ab8WTbj8j7_d3b_DF_fnl4mt8-54aXbMiRssYyClAVgMIKyikyU_EGVcOYtE1dl3ZRKl5TsKZhqKQUXIiqSpIpKTsi55vcPnRfI8ZBr1w02LbgsRujrrkUirHJyDdGE7oYAza6D24FYa0LqieYeiKlJ1JaUv0LU_O0drbNHxcrtH9LW3pJv9nomD757TDoaBx6g9YFNIO2nfv_wA8vqIQK</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>84759330</pqid></control><display><type>article</type><title>Response to ouabain in acutely and chronically failed canine heart-lung preparations</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Spilker, Bert ; Hayden, Michael</creator><creatorcontrib>Spilker, Bert ; Hayden, Michael</creatorcontrib><description>The actions of ouabain were studied in canine heart-lung preparations (HLP) under four different sets of procedures and the therapeutic, irregularity and lethal doses of ouabain determined. Two different methods than those usually used for producing failure in HLP are presented. Acute heart failure was produced by either elevating Starling resistance or administering an excessive amount of the beta-adrenoceptive blocking agent, propranolol. Surgically induced heart-failure was produced by reducing the size of dogs aortae to 20–25% of its original diameter. Ouabain elicited a marked inotropic response in HLP in all three of these procedures, although the response was more rapid in onset in preparations failed acutely than in those which were normal or chronically failed. An increase of dp/dt was found to be a more sensitive criterion of ouabain's beneficial effect, than were criteria formerly used, i.e. an increase in cardiac output or a decrease in right atrial pressure. Our results are in agreement with the view that it is difficult to elicit a beneficial effect to ouabain in normal HLP, but that ouabain's effects may be easily demonstrated in failed preparations. This study demonstrated that the myocardium from chronically failed animals is more sensitive to ouabain in vitro than is the myocardium of normal animals.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/0014-2999(70)90001-4</identifier><identifier>PMID: 5477304</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Aorta - drug effects ; Aortic constriction ; Blood Pressure - drug effects ; Cardiac Output - drug effects ; Constriction ; Dogs ; Female ; Heart - drug effects ; Heart Diseases - drug therapy ; Heart Rate - drug effects ; Heart-failure ; Heart-Lung Machine ; Heart-lung preparation ; In Vitro Techniques ; Male ; Methods ; Ouabain ; Ouabain - therapeutic use ; Propranolol ; Propranolol - administration &amp; dosage ; Propranolol - pharmacology ; Vascular Resistance - drug effects</subject><ispartof>European journal of pharmacology, 1970-01, Vol.11 (3), p.269-277</ispartof><rights>1970</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c423t-e03fd30aa61ae5d5040e3c64fe9f337df882db29480adcf3e977545566df8c203</citedby><cites>FETCH-LOGICAL-c423t-e03fd30aa61ae5d5040e3c64fe9f337df882db29480adcf3e977545566df8c203</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0014-2999(70)90001-4$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/5477304$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Spilker, Bert</creatorcontrib><creatorcontrib>Hayden, Michael</creatorcontrib><title>Response to ouabain in acutely and chronically failed canine heart-lung preparations</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>The actions of ouabain were studied in canine heart-lung preparations (HLP) under four different sets of procedures and the therapeutic, irregularity and lethal doses of ouabain determined. Two different methods than those usually used for producing failure in HLP are presented. Acute heart failure was produced by either elevating Starling resistance or administering an excessive amount of the beta-adrenoceptive blocking agent, propranolol. Surgically induced heart-failure was produced by reducing the size of dogs aortae to 20–25% of its original diameter. Ouabain elicited a marked inotropic response in HLP in all three of these procedures, although the response was more rapid in onset in preparations failed acutely than in those which were normal or chronically failed. An increase of dp/dt was found to be a more sensitive criterion of ouabain's beneficial effect, than were criteria formerly used, i.e. an increase in cardiac output or a decrease in right atrial pressure. Our results are in agreement with the view that it is difficult to elicit a beneficial effect to ouabain in normal HLP, but that ouabain's effects may be easily demonstrated in failed preparations. This study demonstrated that the myocardium from chronically failed animals is more sensitive to ouabain in vitro than is the myocardium of normal animals.</description><subject>Animals</subject><subject>Aorta - drug effects</subject><subject>Aortic constriction</subject><subject>Blood Pressure - drug effects</subject><subject>Cardiac Output - drug effects</subject><subject>Constriction</subject><subject>Dogs</subject><subject>Female</subject><subject>Heart - drug effects</subject><subject>Heart Diseases - drug therapy</subject><subject>Heart Rate - drug effects</subject><subject>Heart-failure</subject><subject>Heart-Lung Machine</subject><subject>Heart-lung preparation</subject><subject>In Vitro Techniques</subject><subject>Male</subject><subject>Methods</subject><subject>Ouabain</subject><subject>Ouabain - therapeutic use</subject><subject>Propranolol</subject><subject>Propranolol - administration &amp; dosage</subject><subject>Propranolol - pharmacology</subject><subject>Vascular Resistance - drug effects</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1970</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kFtLxDAQhYMoul7-gUKfRB-qaZM0zYsgizcQBNHnMJtM3Ug3rUkr7L83dRcfhYFhcs6cIR8hpwW9KmhRXVNa8LxUSl1IeqloGnO-Q2ZFLVVOZVHuktmf5YAcxviZPEKVYp_sCy4lo3xG3l4x9p2PmA1d1o2wAOezVGDGAdt1Bt5mZhk67wy0aW7AtZiewDuP2RIhDHk7-o-sD9hDgMGlsGOy10Ab8WTbj8j7_d3b_DF_fnl4mt8-54aXbMiRssYyClAVgMIKyikyU_EGVcOYtE1dl3ZRKl5TsKZhqKQUXIiqSpIpKTsi55vcPnRfI8ZBr1w02LbgsRujrrkUirHJyDdGE7oYAza6D24FYa0LqieYeiKlJ1JaUv0LU_O0drbNHxcrtH9LW3pJv9nomD757TDoaBx6g9YFNIO2nfv_wA8vqIQK</recordid><startdate>19700101</startdate><enddate>19700101</enddate><creator>Spilker, Bert</creator><creator>Hayden, Michael</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19700101</creationdate><title>Response to ouabain in acutely and chronically failed canine heart-lung preparations</title><author>Spilker, Bert ; Hayden, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-e03fd30aa61ae5d5040e3c64fe9f337df882db29480adcf3e977545566df8c203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1970</creationdate><topic>Animals</topic><topic>Aorta - drug effects</topic><topic>Aortic constriction</topic><topic>Blood Pressure - drug effects</topic><topic>Cardiac Output - drug effects</topic><topic>Constriction</topic><topic>Dogs</topic><topic>Female</topic><topic>Heart - drug effects</topic><topic>Heart Diseases - drug therapy</topic><topic>Heart Rate - drug effects</topic><topic>Heart-failure</topic><topic>Heart-Lung Machine</topic><topic>Heart-lung preparation</topic><topic>In Vitro Techniques</topic><topic>Male</topic><topic>Methods</topic><topic>Ouabain</topic><topic>Ouabain - therapeutic use</topic><topic>Propranolol</topic><topic>Propranolol - administration &amp; dosage</topic><topic>Propranolol - pharmacology</topic><topic>Vascular Resistance - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Spilker, Bert</creatorcontrib><creatorcontrib>Hayden, Michael</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Spilker, Bert</au><au>Hayden, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Response to ouabain in acutely and chronically failed canine heart-lung preparations</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>1970-01-01</date><risdate>1970</risdate><volume>11</volume><issue>3</issue><spage>269</spage><epage>277</epage><pages>269-277</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><abstract>The actions of ouabain were studied in canine heart-lung preparations (HLP) under four different sets of procedures and the therapeutic, irregularity and lethal doses of ouabain determined. Two different methods than those usually used for producing failure in HLP are presented. Acute heart failure was produced by either elevating Starling resistance or administering an excessive amount of the beta-adrenoceptive blocking agent, propranolol. Surgically induced heart-failure was produced by reducing the size of dogs aortae to 20–25% of its original diameter. Ouabain elicited a marked inotropic response in HLP in all three of these procedures, although the response was more rapid in onset in preparations failed acutely than in those which were normal or chronically failed. An increase of dp/dt was found to be a more sensitive criterion of ouabain's beneficial effect, than were criteria formerly used, i.e. an increase in cardiac output or a decrease in right atrial pressure. Our results are in agreement with the view that it is difficult to elicit a beneficial effect to ouabain in normal HLP, but that ouabain's effects may be easily demonstrated in failed preparations. This study demonstrated that the myocardium from chronically failed animals is more sensitive to ouabain in vitro than is the myocardium of normal animals.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>5477304</pmid><doi>10.1016/0014-2999(70)90001-4</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-2999
ispartof European journal of pharmacology, 1970-01, Vol.11 (3), p.269-277
issn 0014-2999
1879-0712
language eng
recordid cdi_proquest_miscellaneous_84759330
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Animals
Aorta - drug effects
Aortic constriction
Blood Pressure - drug effects
Cardiac Output - drug effects
Constriction
Dogs
Female
Heart - drug effects
Heart Diseases - drug therapy
Heart Rate - drug effects
Heart-failure
Heart-Lung Machine
Heart-lung preparation
In Vitro Techniques
Male
Methods
Ouabain
Ouabain - therapeutic use
Propranolol
Propranolol - administration & dosage
Propranolol - pharmacology
Vascular Resistance - drug effects
title Response to ouabain in acutely and chronically failed canine heart-lung preparations
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T15%3A53%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Response%20to%20ouabain%20in%20acutely%20and%20chronically%20failed%20canine%20heart-lung%20preparations&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Spilker,%20Bert&rft.date=1970-01-01&rft.volume=11&rft.issue=3&rft.spage=269&rft.epage=277&rft.pages=269-277&rft.issn=0014-2999&rft.eissn=1879-0712&rft_id=info:doi/10.1016/0014-2999(70)90001-4&rft_dat=%3Cproquest_cross%3E84759330%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=84759330&rft_id=info:pmid/5477304&rft_els_id=0014299970900014&rfr_iscdi=true